Future studies will better clarify the role and the burden of PRL excess or deficiency on metabolic alterations, also investigating the potential role of PRL as a therapeutic target for non-hyperprolactinemic subjects suffering from metabolic diseases. This evidence concerns the gene PRL and Other metabolic disease.